Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist

Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist

A second-generation manufacturing process from 5-(2-methoxyphenoxy)-[2,2‘-bipyrimidine]-4,6-(1H,5H)-dione to bosentan is based on the synthesis and deprotection of the tert-butyl ether of bosentan using available and inexpensive ethylene glycol mono-tert-butyl ether. This new strategy triggered a ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Organic process research & development 2002-03, Vol.6 (2), p.120-124
Hauptverfasser: Harrington, Peter J, Khatri, Hiralal N, DeHoff, Brad S, Guinn, Martin R, Boehler, Mark A, Glaser, Karl A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124
container_issue 2
container_start_page 120
container_title Organic process research & development
container_volume 6
creator Harrington, Peter J
Khatri, Hiralal N
DeHoff, Brad S
Guinn, Martin R
Boehler, Mark A
Glaser, Karl A
description A second-generation manufacturing process from 5-(2-methoxyphenoxy)-[2,2‘-bipyrimidine]-4,6-(1H,5H)-dione to bosentan is based on the synthesis and deprotection of the tert-butyl ether of bosentan using available and inexpensive ethylene glycol mono-tert-butyl ether. This new strategy triggered a cascade of process improvements. Isolations are reduced from six to three, and drying operations, from five to two. Process solvents are reduced from six to two. The isolations of two sensitizers are eliminated. Toluene is used in place of methylene chloride. Two aqueous waste streams are eliminated by replacing DMF and ethylene glycol by toluene. Two methanol−isopropyl acetate recrystallizations of bosentan are replaced by the decantation of a suspension of bosentan formate monoethanolate in ethanol−toluene. Finally, the overall yield is increased from 67 to 84% and the final product purity improved from 99.3 to 99.7%.
doi_str_mv 10.1021/op010234i
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_op010234i</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>b065823837</sourcerecordid><originalsourceid>FETCH-LOGICAL-a257t-25eddcf4a37c7b98d06a335a009d4a99a3a98f52c0099b8f6d71243f915adac73</originalsourceid><addsrcrecordid>eNptkEFLAzEQhYMoWKsH_0EuHgRXk81md3OstVahoFQFb8s0mbRbtsmSrIL_3kjFk6c3zHxveDxCzjm75iznN75nSUXRHpARlznLZF2-H6aZ1SIrecmOyUmMW8aYLHk-IuslRoSgNxScoXf4iZ3vd-gG6i0F-oLaO5PN0WGAofWOPgevMUZqfaC3PiYS3FUy05kzfthg1zq6RI39kIBJuq69a-NwSo4sdBHPfnVM3u5nr9OHbPE0f5xOFhnkshqyXKIx2hYgKl2tVG1YCUJIYEyZApQCAaq2MtdpoVa1LU3F80JYxSUY0JUYk8v9Xx18jAFt04d2B-Gr4az5aaj5ayixF3sWdGy2_iO4lOwf7htRNWYI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist</title><source>ACS Publications</source><creator>Harrington, Peter J ; Khatri, Hiralal N ; DeHoff, Brad S ; Guinn, Martin R ; Boehler, Mark A ; Glaser, Karl A</creator><creatorcontrib>Harrington, Peter J ; Khatri, Hiralal N ; DeHoff, Brad S ; Guinn, Martin R ; Boehler, Mark A ; Glaser, Karl A</creatorcontrib><description>A second-generation manufacturing process from 5-(2-methoxyphenoxy)-[2,2‘-bipyrimidine]-4,6-(1H,5H)-dione to bosentan is based on the synthesis and deprotection of the tert-butyl ether of bosentan using available and inexpensive ethylene glycol mono-tert-butyl ether. This new strategy triggered a cascade of process improvements. Isolations are reduced from six to three, and drying operations, from five to two. Process solvents are reduced from six to two. The isolations of two sensitizers are eliminated. Toluene is used in place of methylene chloride. Two aqueous waste streams are eliminated by replacing DMF and ethylene glycol by toluene. Two methanol−isopropyl acetate recrystallizations of bosentan are replaced by the decantation of a suspension of bosentan formate monoethanolate in ethanol−toluene. Finally, the overall yield is increased from 67 to 84% and the final product purity improved from 99.3 to 99.7%.</description><identifier>ISSN: 1083-6160</identifier><identifier>EISSN: 1520-586X</identifier><identifier>DOI: 10.1021/op010234i</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Organic process research &amp; development, 2002-03, Vol.6 (2), p.120-124</ispartof><rights>Copyright © 2002 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a257t-25eddcf4a37c7b98d06a335a009d4a99a3a98f52c0099b8f6d71243f915adac73</citedby><cites>FETCH-LOGICAL-a257t-25eddcf4a37c7b98d06a335a009d4a99a3a98f52c0099b8f6d71243f915adac73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/op010234i$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/op010234i$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids></links><search><creatorcontrib>Harrington, Peter J</creatorcontrib><creatorcontrib>Khatri, Hiralal N</creatorcontrib><creatorcontrib>DeHoff, Brad S</creatorcontrib><creatorcontrib>Guinn, Martin R</creatorcontrib><creatorcontrib>Boehler, Mark A</creatorcontrib><creatorcontrib>Glaser, Karl A</creatorcontrib><title>Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist</title><title>Organic process research &amp; development</title><addtitle>Org. Process Res. Dev</addtitle><description>A second-generation manufacturing process from 5-(2-methoxyphenoxy)-[2,2‘-bipyrimidine]-4,6-(1H,5H)-dione to bosentan is based on the synthesis and deprotection of the tert-butyl ether of bosentan using available and inexpensive ethylene glycol mono-tert-butyl ether. This new strategy triggered a cascade of process improvements. Isolations are reduced from six to three, and drying operations, from five to two. Process solvents are reduced from six to two. The isolations of two sensitizers are eliminated. Toluene is used in place of methylene chloride. Two aqueous waste streams are eliminated by replacing DMF and ethylene glycol by toluene. Two methanol−isopropyl acetate recrystallizations of bosentan are replaced by the decantation of a suspension of bosentan formate monoethanolate in ethanol−toluene. Finally, the overall yield is increased from 67 to 84% and the final product purity improved from 99.3 to 99.7%.</description><issn>1083-6160</issn><issn>1520-586X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNptkEFLAzEQhYMoWKsH_0EuHgRXk81md3OstVahoFQFb8s0mbRbtsmSrIL_3kjFk6c3zHxveDxCzjm75iznN75nSUXRHpARlznLZF2-H6aZ1SIrecmOyUmMW8aYLHk-IuslRoSgNxScoXf4iZ3vd-gG6i0F-oLaO5PN0WGAofWOPgevMUZqfaC3PiYS3FUy05kzfthg1zq6RI39kIBJuq69a-NwSo4sdBHPfnVM3u5nr9OHbPE0f5xOFhnkshqyXKIx2hYgKl2tVG1YCUJIYEyZApQCAaq2MtdpoVa1LU3F80JYxSUY0JUYk8v9Xx18jAFt04d2B-Gr4az5aaj5ayixF3sWdGy2_iO4lOwf7htRNWYI</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>Harrington, Peter J</creator><creator>Khatri, Hiralal N</creator><creator>DeHoff, Brad S</creator><creator>Guinn, Martin R</creator><creator>Boehler, Mark A</creator><creator>Glaser, Karl A</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20020301</creationdate><title>Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist</title><author>Harrington, Peter J ; Khatri, Hiralal N ; DeHoff, Brad S ; Guinn, Martin R ; Boehler, Mark A ; Glaser, Karl A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a257t-25eddcf4a37c7b98d06a335a009d4a99a3a98f52c0099b8f6d71243f915adac73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harrington, Peter J</creatorcontrib><creatorcontrib>Khatri, Hiralal N</creatorcontrib><creatorcontrib>DeHoff, Brad S</creatorcontrib><creatorcontrib>Guinn, Martin R</creatorcontrib><creatorcontrib>Boehler, Mark A</creatorcontrib><creatorcontrib>Glaser, Karl A</creatorcontrib><collection>CrossRef</collection><jtitle>Organic process research &amp; development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harrington, Peter J</au><au>Khatri, Hiralal N</au><au>DeHoff, Brad S</au><au>Guinn, Martin R</au><au>Boehler, Mark A</au><au>Glaser, Karl A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist</atitle><jtitle>Organic process research &amp; development</jtitle><addtitle>Org. Process Res. Dev</addtitle><date>2002-03-01</date><risdate>2002</risdate><volume>6</volume><issue>2</issue><spage>120</spage><epage>124</epage><pages>120-124</pages><issn>1083-6160</issn><eissn>1520-586X</eissn><abstract>A second-generation manufacturing process from 5-(2-methoxyphenoxy)-[2,2‘-bipyrimidine]-4,6-(1H,5H)-dione to bosentan is based on the synthesis and deprotection of the tert-butyl ether of bosentan using available and inexpensive ethylene glycol mono-tert-butyl ether. This new strategy triggered a cascade of process improvements. Isolations are reduced from six to three, and drying operations, from five to two. Process solvents are reduced from six to two. The isolations of two sensitizers are eliminated. Toluene is used in place of methylene chloride. Two aqueous waste streams are eliminated by replacing DMF and ethylene glycol by toluene. Two methanol−isopropyl acetate recrystallizations of bosentan are replaced by the decantation of a suspension of bosentan formate monoethanolate in ethanol−toluene. Finally, the overall yield is increased from 67 to 84% and the final product purity improved from 99.3 to 99.7%.</abstract><pub>American Chemical Society</pub><doi>10.1021/op010234i</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1083-6160
ispartof Organic process research & development, 2002-03, Vol.6 (2), p.120-124
issn 1083-6160
1520-586X
language eng
recordid cdi_crossref_primary_10_1021_op010234i
source ACS Publications
title Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T18%3A28%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20and%20Development%20of%20a%20Second-Generation%20Process%20for%20Bosentan,%20an%20Endothelin%20Receptor%20Antagonist&rft.jtitle=Organic%20process%20research%20&%20development&rft.au=Harrington,%20Peter%20J&rft.date=2002-03-01&rft.volume=6&rft.issue=2&rft.spage=120&rft.epage=124&rft.pages=120-124&rft.issn=1083-6160&rft.eissn=1520-586X&rft_id=info:doi/10.1021/op010234i&rft_dat=%3Cacs_cross%3Eb065823837%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true